GGrantIndex
← Leaderboards

Satish Sc Rao

University Of Iowa

$7,638,812
Attributed
$18,206,121
Total exposure
15
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,206,121 · 15

By mechanism

U01$9,061,350 · 2
R01$8,004,530 · 3
U34$711,433 · 1
R21$395,365 · 1
M01$33,443 · 8

Top collaborators

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Feces

Research focus

FecesQuality Of LifeAnusSymptomsBaseResponseRectalPressureAffectFecal IncontinenceEvoked PotentialsEsthesiaRandomizedConstipationCostClinical ResearchFunctional DisorderSphincter Ani Muscle StructurePeripheralRandomized Controlled TrialsIntestinesSignal TransductionNeuronsBiofeedback

Grant awards (43)

Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$535,092
R01 · FY2025 · DK
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$652,851
R01 · FY2024 · DK
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$717,356
R01 · FY2023 · DK
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL$406,116
R01 · FY2023 · DK · contact PI
Fecal Incontinence Treatment Study (FIT Study)$1,319,046
U01 · FY2022 · DK
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$762,766
R01 · FY2022 · DK
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL$510,467
R01 · FY2022 · DK · contact PI
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL$523,978
R01 · FY2021 · DK · contact PI
Fecal Incontinence Treatment Study (FIT Study)$2,400,000
U01 · FY2020 · DK
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL$553,167
R01 · FY2020 · DK · contact PI
Fecal Incontinence Treatment Study (FIT Study)$2,400,000
U01 · FY2019 · DK
TRANSLUMBOSACRAL NEUROMODULATION THERAPY FOR FECAL INCONTINENCE: RANDOMIZED TRIAL$597,973
R01 · FY2019 · DK · contact PI
Fecal Incontinence Treatment Study (FIT Study)$2,491,974
U01 · FY2018 · DK
Comparative Effectiveness of Biofeedback, Sacral Nerve Stimulation, and Injectable Bulking Agents for Treatment of Fecal Incontinence$326,318
U34 · FY2017 · DK
Comparative Effectiveness of Biofeedback, Sacral Nerve Stimulation, and Injectable Bulking Agents for Treatment of Fecal Incontinence$385,115
U34 · FY2016 · DK
NEUROMODULATION THERAPY FOR FECAL INCONTINENCE$177,232
R21 · FY2016 · DK · contact PI
NEUROMODULATION THERAPY FOR FECAL INCONTINENCE$218,133
R21 · FY2015 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$278,521
R01 · FY2011 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$14,963
R01 · FY2011 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$298,337
R01 · FY2010 · DK · contact PI
Interstitial Cystitis/Painful Bladder Syndrome and Irritable Bowel Syndrome$150,110
U01 · FY2010 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$293,314
R01 · FY2009 · DK · contact PI
Interstitial Cystitis/Painful Bladder Syndrome and Irritable Bowel Syndrome$150,110
U01 · FY2009 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$295,022
R01 · FY2008 · DK · contact PI
Interstitial Cystitis/Painful Bladder Syndrome and Irritable Bowel Syndrome$150,110
U01 · FY2008 · DK · contact PI
Novel Treatment Strategies for Constipation and Role of Brain-Gut axis$300,407
R01 · FY2007 · DK · contact PI
INVESTIGATION OF ADENOSINE IN THE PATHOGENESIS OF NONCARDIAC CHEST PAIN$2,978
M01 · FY2006 · RR · contact PI
NEUROMUSCULAR CONDITIONING THERAPY FOR DYSSYNERGIC DEFECATION$331
M01 · FY2006 · RR · contact PI
NEUROMUSCULAR CONDITIONING THERAPY FOR DYSSYNERGIC DEFECATION$5,180
M01 · FY2005 · RR
INVESTIGATION OF ADENOSINE IN THE PATHOGENESIS OF NONCARDIAC CHEST PAIN$2,266
M01 · FY2005 · RR
CHRONIC ANORECTAL PAIN AND ITS TREATMENT WITH BOTOX$323
M01 · FY2005 · RR
NEUROMUSCULAR CONDITION THERAPY-DYSSYNERGIC DEFECATION$252,840
R01 · FY2004 · DK
Chronic Anorectal Pain and Its Treatment with Botox$337
M01 · FY2004 · RR
NEUROMUSCULAR CONDITION THERAPY-DYSSYNERGIC DEFECATION$252,840
R01 · FY2003 · DK
NEUROMUSCULAR CONDITION THERAPY-DYSSYNERGIC DEFECATION$252,840
R01 · FY2002 · DK
PHYSIOLOGY OF COLONIC FUNCTION AND DEFECATION USING COLONIC MOTILITY$0
M01 · FY2002 · RR
PATHOPHYSIOLOGY OF CHRONIC ANORECTAL PAIN AND BOTOX TREATMENT$0
M01 · FY2002 · RR
NEUROMUSCULAR CONDITION THERAPY-DYSSYNERGIC DEFECATION$252,840
R01 · FY2001 · DK
PHYSIOLOGY OF COLONIC FUNCTION AND DEFECATION USING COLONIC MOTILITY$0
M01 · FY2001 · RR
PATHOPHYSIOLOGY OF CHRONIC ANORECTAL PAIN AND BOTOX TREATMENT$0
M01 · FY2001 · RR
NEUROMUSCULAR CONDITION THERAPY-DYSSYNERGIC DEFECATION$252,840
R01 · FY2000 · DK
PHYSIOLOGY OF COLONIC FUNCTION AND DEFECATION USING COLONIC MOTILITY$22,028
M01 · FY2000 · RR
PATHOPHYSIOLOGY OF CHRONIC ANORECTAL PAIN AND BOTOX TREATMENT$0
M01 · FY2000 · RR